QBE.AU

23.11

+1.4%↑

EVN.AU

8.85

+3.03%↑

BEN.AU

11.77

-0.93%↓

BOQ.AU

7.7

-0.13%↓

CGF.AU

7.5

-0.66%↓

QBE.AU

23.11

+1.4%↑

EVN.AU

8.85

+3.03%↑

BEN.AU

11.77

-0.93%↓

BOQ.AU

7.7

-0.13%↓

CGF.AU

7.5

-0.66%↓

QBE.AU

23.11

+1.4%↑

EVN.AU

8.85

+3.03%↑

BEN.AU

11.77

-0.93%↓

BOQ.AU

7.7

-0.13%↓

CGF.AU

7.5

-0.66%↓

QBE.AU

23.11

+1.4%↑

EVN.AU

8.85

+3.03%↑

BEN.AU

11.77

-0.93%↓

BOQ.AU

7.7

-0.13%↓

CGF.AU

7.5

-0.66%↓

QBE.AU

23.11

+1.4%↑

EVN.AU

8.85

+3.03%↑

BEN.AU

11.77

-0.93%↓

BOQ.AU

7.7

-0.13%↓

CGF.AU

7.5

-0.66%↓

Search

Nanosonics Ltd

Uždarymo kaina

SektoriusFinansų sektorius

4.44 -0.89

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.35

Max

4.45

Pagrindiniai rodikliai

By Trading Economics

Pajamos

3M

9.8M

Pardavimai

3.2M

94M

P/E

Sektoriaus vid.

86.8

25.623

Pelnas, tenkantis vienai akcijai

0.011

Pelno marža

10.428

Darbuotojai

466

EBITDA

-2.8M

9.8M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+11.49% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

273M

1.3B

Ankstesnė atidarymo kaina

5.33

Ankstesnė uždarymo kaina

4.44

Naujienos nuotaikos

By Acuity

50%

50%

233 / 539 reitingas Finance

Nanosonics Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-21 23:25; UTC

Karštos akcijos

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

2025-05-21 21:57; UTC

Įsigijimai, susijungimai, perėmimai

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

2025-05-21 21:29; UTC

Įsigijimai, susijungimai, perėmimai

Millicom to Acquire Telefónica's Operations in Uruguay

2025-05-21 21:01; UTC

Pagrindinės rinkos jėgos

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

2025-05-21 23:49; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

2025-05-21 23:37; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2025-05-21 23:33; UTC

Įsigijimai, susijungimai, perėmimai

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

2025-05-21 23:32; UTC

Įsigijimai, susijungimai, perėmimai

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

2025-05-21 23:32; UTC

Įsigijimai, susijungimai, perėmimai

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

2025-05-21 23:32; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

2025-05-21 23:31; UTC

Įsigijimai, susijungimai, perėmimai

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

2025-05-21 23:30; UTC

Įsigijimai, susijungimai, perėmimai

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

2025-05-21 23:30; UTC

Įsigijimai, susijungimai, perėmimai

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

2025-05-21 23:29; UTC

Įsigijimai, susijungimai, perėmimai

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

2025-05-21 23:28; UTC

Uždarbis

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

2025-05-21 23:27; UTC

Uždarbis

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

2025-05-21 23:26; UTC

Uždarbis

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

2025-05-21 23:26; UTC

Uždarbis

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

2025-05-21 23:26; UTC

Uždarbis

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

2025-05-21 23:23; UTC

Įsigijimai, susijungimai, perėmimai

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

2025-05-21 23:22; UTC

Svarbiausios naujienos

Walmart to Cut 1,500 Corporate Jobs in Restructuring -- WSJ

2025-05-21 23:22; UTC

Įsigijimai, susijungimai, perėmimai

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

2025-05-21 23:20; UTC

Įsigijimai, susijungimai, perėmimai

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

2025-05-21 23:18; UTC

Įsigijimai, susijungimai, perėmimai

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

2025-05-21 23:04; UTC

Svarbiausios naujienos

EV Owners Face Annual Fee Under Proposed Tax Bill -- Barrons.com

2025-05-21 21:46; UTC

Svarbiausios naujienos

NBCUniversal Bids for MLB Rights That Were Dropped by ESPN -- WSJ

2025-05-21 21:42; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

2025-05-21 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Millicom to Acquire Telefónica's Ops in Uruguay

2025-05-21 21:07; UTC

Svarbiausios naujienos

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

2025-05-21 21:06; UTC

Įsigijimai, susijungimai, perėmimai

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Nanosonics Ltd Prognozė

Kainos tikslas

By TipRanks

11.49% į viršų

12 mėnesių prognozė

Vidutinis 4.928 AUD  11.49%

Aukščiausias 6 AUD

Žemiausias 4 AUD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Nanosonics Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

4

Pirkti

2

Laikyti

2

Parduoti

Rinkos nuotaikos

By Acuity

233 / 539 reitingas Finansų sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Nanosonics Ltd

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.